Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03684837
Other study ID # COPDinfl
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date March 20, 2018
Est. completion date September 30, 2018

Study information

Verified date September 2018
Source Universidade Federal de Pernambuco
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Older with Chronic obstructive Pulmonary Disease (COPD) were submitted to chronic whole body vibration training during 03 months, receiving a vitamine D dose for each week or placebo vitamine. This group was compared with healthy older which were submitted to the same intervention.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 59
Est. completion date September 30, 2018
Est. primary completion date August 30, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years to 75 Years
Eligibility Inclusion Criteria:

- Older patients with COPD

- Both genders

- Sedentary according to International Physical Activity Questionnaire (IPAQ) short form

- BMI in between 22.9 and 28 kg/m2.

- Older patients with COPD should have a clinical-functional diagnosis of the disease according to GOLD (GOLD, 2018), have been ex-smokers and have not used corticosteroids or have used this drug in a stable way for at least one year (without dosage or medication modifications).

- Older volunteers should be self-referenced healthy or, if they had systemic arterial hypertension or diabetes mellitus, these comorbidities should be controlled by diet or regular medication use.

Exclusion Criteria:

- Older patients with COPD who had episodes of exacerbation in the last three months, those with pulmonary rehabilitation programs in the last year, those who used home oxygen therapy, and patients with COPD-associated comorbidities were excluded.

- Volunteers of both groups who were taking vitamin D were excluded, as well as the current smokers, although occasional, volunteers with a history of labyrinthitis or thromboembolism, who had undergone surgical procedures of any size in the last year, such as plaques, pins or cardiac pacemakers, those with unconsolidated fractures that used medications that affected bone metabolism or lean mass, or those who had difficulties adapting to the assessment or the training protocol.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Vitamine D supplementation
a vitamine D dose for week
Other:
chronic exercise in whole body vibration (WBV)
exercise in WBV during 03 months, e times per week

Locations

Country Name City State
Brazil Federal University of Pernambuco Recife Pernambuco

Sponsors (1)

Lead Sponsor Collaborator
Maíra F Pessoa

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Functional capacity Change in walk distance achieved in metres, measured during the six minute walk test before and immediately up to 12 weeks in WBV training.
Secondary Balance static and dynamic Change in total scores of Tinetti index, composed by 16 items divided into 2 sections: static balance (9 items) with 16 points and gait or dynamic balance (7 items) with 12 points, summed in a total score of 28 points. Individuals scoring < 26 points have a risk for falling. before and immediately up to 12 weeks in WBV training.
Secondary Gait speed Change in time in seconds registered in Timed Up and Go test before and immediately up to 12 weeks in WBV training.
Secondary Body composition Change in electrical bioimpedance measuring the fat mass and lean mass in kilograms each one, in total body before and immediately up to 12 weeks in WBV training.
Secondary Quality of life measure by WHOQOL Change in total value obtained from WHOQOL-old questionnaire (World Health Organization of Quality Of Life) that evaluate in older the domains: sensory abilities; autonomy; past, present and future activities; social participation; death & dying; and intimacy. The Quality of life needs to improve when it is 1 to 2,9; is regular 3 to 3.9 points; good between 4 up to 4.9 and very good with 5 points. before and immediately up to 12 weeks in WBV training.
Secondary Peripheral strength Change in mean value obtained from 03 maneuvers of isokinetic contraction in a hand dynamometer (device that measure strength in handgrip), measured in centimeters of water. before and immediately up to 12 weeks in WBV training.
Secondary Respiratory strength Change in major value obtained after 03 maneuvers in manovacuometer (device that measure manometry for expiratory pressure and vacuum generated for the inspiratory pressure), all in centimeters of water. before and immediately up to 12 weeks in WBV training.
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT06000696 - Healthy at Home Pilot
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
Completed NCT04043728 - Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study N/A
Completed NCT04105075 - COPD in Obese Patients
Recruiting NCT05825261 - Exploring Novel Biomarkers for Emphysema Detection
Active, not recruiting NCT04075331 - Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial Phase 2/Phase 3
Terminated NCT03640260 - Respiratory Regulation With Biofeedback in COPD N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
Withdrawn NCT04210050 - Sleep Ventilation for Patients With Advanced Hypercapnic COPD N/A
Terminated NCT03284203 - Feasibility of At-Home Handheld Spirometry N/A
Recruiting NCT06110403 - Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness Phase 1/Phase 2
Active, not recruiting NCT06040424 - Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Recruiting NCT04868357 - Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program N/A
Completed NCT01892566 - Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV N/A
Completed NCT04119856 - Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD N/A
Completed NCT04485741 - Strados System at Center of Excellence
Completed NCT03626519 - Effects of Menthol on Dyspnoea in COPD Patients N/A
Recruiting NCT04860375 - Multidisciplinary Management of Severe COPD N/A